Viewing Study NCT02509494


Ignite Creation Date: 2025-12-25 @ 1:46 AM
Ignite Modification Date: 2026-01-06 @ 2:28 PM
Study NCT ID: NCT02509494
Status: COMPLETED
Last Update Posted: 2022-07-18
First Post: 2015-06-24
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Staged Phase 3 Study to Assess the Safety and Immunogenicity of Ebola Candidate Vaccines Ad26.ZEBOV and MVA-BN-Filo
Sponsor: Janssen Vaccines & Prevention B.V.
Organization: